S&P revises UAB Medicine’s outlook to negative over weaker operations

S&P Global Ratings revised Birmingham, Ala.-based UAB Medicine’s outlook to negative from stable.

Advertisement

S&P also affirmed its “AA-” long term rating on the health system’s revenue bonds.

The outlook revision is a result of UAB Medicine’s weaker operating margins in the last two fiscal years, which resulted in a lowered annual debt service coverage. The new maximum annual debt service coverage is not in line with its current “AA-” long-term rating.

More articles on healthcare finance:
TransUnion Healthcare keeping contract with VA 
41 hospital, health system outlook and credit rating actions in July
Proposed physician fee changes credit negative for academic med centers, some rural hospitals, Moody’s says

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

Reconsider What’s Possible: Enterprise RCM and the Pro-Fee Practice

Tuesday, July 28
11:00 AM - 12:00 PM CDT

Presenters: Garett Kreitz, Med-MetrixJohn Stefanowicz, Med-Metrix

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.